At The Fountain, we use advanced diagnostics to uncover what bloodwork alone often misses, then help you understand what the information means, what matters most, and what comes next
Avexitide showed significant efficacy in reducing severe hypoglycemic events in Phase 2 trials and is set to enter Phase 3 trials for PBH in early 2025 In February 2024, Eli Lilly and Company anticipated launching Mounjaro, its highly successful diabetic medication and obesity treatment, in India as early as next year if it passes an ongoing regulatory evaluation
Antibiotics as major disruptors of gut microbiota
Frank Watanabe, president and CEO of Arcutis, expressed pride in ZORYVEs approval as a steroid-free solution for AD, marking the third FDA approval for Arcutis in two years
The GLP-1 pathway primarily controls hunger and satiety signals, while metformin improves how your cells respond to insulin and utilize glucose